Financial reasons are the most likely explanation for the lack of consistency between clinical practice and clinical guidelines in the management of women with advanced breast cancer. International guest speaker Professor Fatima Cardoso told the MOGA ASM that endocrine therapy was the preferred option for all hormone receptor positive disease, even in the presence of ...
Updated: Treatment choices never as simple as ABC
By Mardi Chapman
4 Aug 2017